Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12337498 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL11960999 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL12313768 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL16594894 | 0.98 | THRB (0.40) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL3344825 | 0.98 | THRB (0.40) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL15573458 | 0.98 | THRB (0.40) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL1491305 | 0.98 | THRB (0.40) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL2121705 | 0.98 | THRB (0.40) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL2632390 | 0.98 | THRB (0.40) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL10877344 | 0.98 | THRB (0.40) | CA12CA1CA2CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110182805-A1 | Nanoparticle fabrication methods, systems, and materials | NATIONAL SCIENCE FOUNDATION | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110182805-A1 | Nanoparticle fabrication methods, systems, and materials | TTN, TAGLN2, TLN1 | CA12 1146/4885CA1 2384/4885CA2 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.